Meghan focuses her practice on intellectual property litigation, with a concentration on patent and trade secrets litigation. She has handled all phases of litigation, including pre-suit investigations and fact and expert discovery. She has argued at a Markman hearing, and has gone to trial several times.
Meghan’s biology background and experience in the pharmaceutical and medical device spaces make her a valuable advisor to life sciences companies. She frequently represents pharmaceutical and medical device companies in patent litigations. In addition to litigation, she counsels life sciences clients on the intersection of patent law with FDA regulatory issues, as well as in licensing and transactional matters.
While in law school, Meghan worked with start-ups seeking to commercialize several medical devices as part of Emory Law School’s TI:GER® program, and completed an internship at a pharmaceutical company. While earning her undergraduate degree in biology, she worked in a genetics laboratory and interned in the Medical Affairs department of a pharmaceutical company.
Outside of the life sciences space, Meghan has litigated patent, trade secret, trademark, and unfair competition cases in other industries, including telecommunications, electronics, flooring, cement and concrete.
Meghan also maintains an active pro bono practice. She helps clients who are seeking asylum, dealing with housing disputes, and who need help with intellectual property issues.
Obtained summary judgment of non-infringement concerning patents covering an over-the-counter cough and cold medication.
Obtained a trial victory invalidating a U.S. patent covering an oral contraceptive.
Represented a medical device manufacturer in a competitor-versus-competitor patent case involving soft tissue augmentation.
Represented pharmaceutical companies in patent litigation matters involving drugs used to treat depression, HIV, cancer, ocular infections, ADHD, overactive bladder and chronic kidney disease, as well as several women’s health products.
Advised pharmaceutical companies in the pre-suit context concerning Paragraph IV Notice Letters under the FDA’s Hatch-Waxman Act.
Represented a pharmaceutical company in a pharmaceutical antitrust suit.
Represented pharmaceutical and life sciences companies in negotiating product acquisition, manufacturing and supply agreements.
Defended a major telecommunications company in a jury trial.
Represented a large carpet manufacturer in a patent dispute.
Member, Atlanta Intellectual Property Inn of Court
Member, Intellectual Property Section, State Bar of Georgia
Named to “Georgia Rising Stars,” Intellectual Property, Super Lawyers, Thomson Reuters, 2016-2020